Johnson & Johnson, which said it made the decision based on a market assessment, did not specify the markets it is leaving or ...

Bloomberg reports today that Johnson & Johnson intends to take its Linx reflux management system off the market outside the U ...

Johnson & Johnson (NYSE:JNJ) is one of the best conservative stocks to buy now. On September 23, the company announced plans ...

LIMA — Dr. Jeremy Heffner, general surgeon at Lima Memorial Health System, has recently performed more than 100 LINX Reflux Management System procedures. According to a recent press release, Heffner’s ...

Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move ...

For 10 years, 54-year-old Tricia Carr couldn't stomach a typical American breakfast. Her acid reflux was getting worse. Since medications didn't work for her, she decided to try a minimally invasive ...

Johnson & Johnson Medical Devices Companies subsidiary Ethicon’s Linx Reflux Management System was “significantly more effective” at treating gastrointestinal reflux disease than acid suppression ...

One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...

The company has decided to withdraw the product, called LINX Reflux Management System, from March for commercial reasons, and ...

Johnson & Johnson (NYSE:JNJ) announced plans to remove its LINX Reflux Management System from markets outside the United ...

Johnson & Johnson will halt international sales of its Linx reflux device, sparking concern among surgeons over limited options for GERD patients.

A UK-wide research team, led by the University of Oxford's Nuffield Department of Surgical Sciences, has launched a major international study to improve surgical treatment for people suffering from ...